| Literature DB >> 56590 |
A B Anderson, P J Haynes, J Guillebaud, A C Turnbull.
Abstract
Six patients with menorrhagia due to dysfunctional uterine bleeding and one patient with an intrauterine contraceptive device were treated with prostaglandin-synthetase inhibitors in an attempt to reduce their excessive menstrual blood-loss. Mefenamic acid (six patients) or flufenamic acid (one patient) taken during menstruation for 2-3 cycles reduced menstrual loss in each patient. These preliminary observations suggest a new treatment for a common gynaecological problem and could imply that prostaglandins are involved in the aetiology of excessive menstrual blood-loss in such patients.Entities:
Mesh:
Substances:
Year: 1976 PMID: 56590 DOI: 10.1016/s0140-6736(76)91612-3
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321